期刊文献+

左心疾病相关性肺动脉高压预后的研究进展 被引量:15

下载PDF
导出
摘要 左心疾病相关性肺动脉高压是肺动脉高压中最常见的类型,其患病率高,预后差,所以准确评估这一类肺动脉高压患者的预后对指导治疗具有重要的意义。目前尚没有可靠的左心疾病相关性肺动脉高压的风险评估体系。研究显示一些临床指标、多普勒超声心动图指标、血流动力学指标及合并症可以评估这类肺动脉高压患者的预后,对其危险分层有一定的价值。但关于这类肺动脉高压的研究尚处于起步阶段,在其发病机制、诊断、治疗和预后方面还有待于进一步的探索。
作者 杨涛 何建国
出处 《中国循环杂志》 CSCD 北大核心 2013年第3期237-239,共3页 Chinese Circulation Journal
基金 国家“十二五”科技支撑计划项目(2011BAI11B15)
  • 相关文献

参考文献26

  • 1Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J, 1987,8:23-26.
  • 2Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA, 2003,289:194-202.
  • 3顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1276
  • 4张玉英,范维琥.心力衰竭的流行病学及诊治现状[J].中国循环杂志,2004,19(1):74-76. 被引量:20
  • 5Butler J, Chomsky DB, Wilson JR, et al. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol,1999, 34:1802- 1806.
  • 6Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coil Cardiol, 2001, 37:183-188.
  • 7Lam CS, Roger VL, Rodeheffer RJ, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community- based study. J Am Coil Cardiol,2009,53:l 119-1126.
  • 8Damy T, Goode KM, Kallvikbacka-Bennett A, et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J, 2010, 31:2280-2290.
  • 9Richa A, Sanjiv J, Aimee J, et al. Risk Assessment in Pulmonary Hypertension Associated with Heart Failure and Preserved Ejection Fraction. J Heart Lung Transplant, 2012,31:467-477.
  • 10Jesper K, Dilek A, Kasper K, et al. Prognostic Importance of Pulmonary Hypertension in Patients With Heart Failure. Am J Cardiol, 2007, 99:1146-1150.

二级参考文献22

  • 1Chemla D, Castelain V, Herre P, et al. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J,2002,20(5) :1314-1331.
  • 2Galie N, Manes A, Palazzini, Met al. Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension. Eur Heart J,2007,9 :H68-74.
  • 3Dias CA, Assad RS, Caneo LF, et al. Reversible pulmonary trunk banding. Ⅱ :an experimental model for rapid pulmonary ventricular hypertrophy. J Thorac Cardiovasc Surg,2002,124:999-1006.
  • 4Abraham WT, Raynolds MV, Gottschall B, et al. Importance of an- giotensin-converting enzyme in pulmonary hypertension. Cardiology, 1995 ,86:9-15.
  • 5Barst RJ,McGoon M,Torbieki A,et al. Diagnosis and differential as- sessment of pulmonary arterial hypertension. J Am Coll Cardiol,2004, 43:40S-47S.
  • 6Khush KK ,Tasissa G, Butler J, et al. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure : analysis of the Evalua- tion Study of Congestive Heart Failure and Pulmonary Artery Catheter- ization Effectiveness (ESCAPE) database. Am Heart J,2009,157 (6) :1026-1034.
  • 7Lain CS, Roger VL, Rodeheffer R J, et al. Puhnonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol,2009,53:1119-1126.
  • 8Cowie MR,Struthers AD, Wood DA, et al . Value of natriuretic pep- tides in assessment of patients with possible new heart failure in pri- mary care. Lancet, 1997,350 : 1549-1353.
  • 9Souza R,Bogossian HB, Humbert M,et al. N-terminal-pro-brain natri- uretic peptide as a haemodynamic marker in idiopathic pulmonary ar- terial hypertension. Eur Respir J, 2005,25 ( 3 ) : 509-513.
  • 10Cracowski JL, Yaici A, Sitbon O, et al. Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study de- sign. Rev Mal Respir,2004,21 (6 Pt 1 ) :1137-1143.

共引文献1311

同被引文献180

引证文献15

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部